Searched for
GSK PHARMACEUTICALS LTD.
$10. 6 billion deal: GSK to buy US cancer specialist NuvalentBritish pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...- Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
- GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...
- Dividends, bonus issues: TCS, LIC, Bajaj Auto among 30 stocks turning ex-date this week. Check detailsInvestors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...
- NCLAT allows Lyka Labs appeal; asks Modi Lifecare to pay Rs 63 lakh or face insolvency proceedingsThe NCLAT has ruled in favor of Lyka Labs. It overturned a previous NCLT decision. Modi Lifecare Industries must now pay Rs 63 lakh within ...
- GSK's Calpol a well-known trademark: High CourtThe Delhi High Court has recognized GlaxoSmithKline Pharmaceuticals' pain and fever medicine, Calpol, as a well-known trademark. This desig...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Experimental pancreatic cancer drug appears to dramatically improve one year survival ratesA groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...
- Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...
- Maharashtra targets Rs 30 lakh crore inflows to become a global investment hubMaharashtra targets ₹30 lakh crore in investments to become a global hub. The state is focusing on infrastructure, logistics, and clean ene...
- GSK sends notices to Akums, Associate over 'Zinetac' brandThe Indian unit of British drugmaker GSK further alleged that Nicholas Healthcare and Akums are also using identical packaging to take adva...
- Optimising product portfolio, focusing on key brands: GSK Pharmaceuticals"The business has embarked on it new strategy this year, as we put in place an optimal commercial structure and worked at building capabili...
- $1 billion bet: GSK Pharma a short-term sell, long-term buy, say expertsThe stock is at rich valuations despite low sales and profit growth. The open offer by its parent firm is attractively priced, say experts.
- No major surprise on GSK Pharma offer: Dipen ShanGSK, which holds 50.7 per cent stake, wants to raise up to 75 per cent at a price of Rs 3,100 a share.
- GSK Pharma rallies 20% as parent initiates open offerThe parent of GlaxoSmithKline Pharmaceuticals Ltd plans to increase its stake from 50.7 per cent to up to 75 per cent at an offer price of ...
- GlaxoSmithKline Pharmaceuticals Q3 net up 4.44% at Rs 152.34 croreGlaxoSmithKline today reported 4.44 per cent rise in net profit at Rs 152.34 crore for the quarter ended September 30, 2012 on back of robu...
- GlaxoSmithKline Pharma Q3 net dips 7.57% to Rs 145.86 crGSK Pharmaceuticals today reported 7.57 per cent decline in net profit for the third quarter ended September 30, 2011 to Rs 145.86 crore.
- Glaxo to step up capacity for elephantiasis drug productionBritish drugmaker GlaxoSmithKline (GSK) will increase its capacity to make a drug for the treatment of elephantiasis at its manufacturing f...
- GSK to lower prices to woo India mktGlaxoSmithKline CEO Andrew Witty says the pharma major plans to invest Rs 430 crore to develop vaccines here.
- GSK enters into agreement with Japan-based Astellas PharmaDrug firm GlaxoSmithkline Pharmaceuticals on Monday said it has enter into a collaboration with the Japan-based Astellas Pharma Inc for sel...
Load More
